Keynote Session

08:40-09:20 Dai-ichi Tsuru Plenary:Natural variation of a signalling lipid. Markus Wenk (National University of Singapore)

09:30-10:10 Dai-ichi Tsuru Use of metabolomics in systems biology: from data to understanding. Bas Teusink (University of Amsterdam, the Netherlands) 

09:30-10:10 Marica Hall From mice to man and back again: applications of metabolomics to understand type 2 diabetes and obesity. Julian L Griffin (University of Cambridge, UK)

Session 2A-D: Flux, Microbiology & Parasitology

Dai-ichi Tsuru

Choong Hwan Lee & David Watson

10:30-10:45 2A-D1: Identification of the metabolic reprogramming underlying metastasis in prostate cancer by combining multi-omic approach and model-driven data analysis. Marta Cascante (University of Barcelona, Spain)

10:45-11:00 2A-D2: OpenMebius: An Open source software for metabolic flux analysis. Hiroshi Shimizu (Osaka University, Japan)

11:00-11:15 2A-D3: Quantitative metabolic modeling for biofuel production at the Joint BioEnergy Institute. Hector Garcia Martin (Lawrence Berkeley National Lab, USA)

11:15-11:30 2A-D4: Stable-isotope labelled metabolomics for network-wide discovery of stage-specific pathways in Trypanosoma brucei. Darren Creek (Monash University, Australia)

11:30-11:45 2A-D5: An altered M. tuberculosis metabolome induced by katG mutations resulting in drug resistance. Du Toit Loots (North-West University, South Africa)

11:45-12:00 2A-D6: LC-HRMS fingerprinting: an innovative strategy to investigate bacterial metabolome during cheese ripening. Clementine Le Boucher (INRA, France)

Session 2A-M: Drug & Medicine

Marica Hall

Rima Kaddurah-Daouk & Martin Robert

10:30-10:45 2A-M1: Ceramide metabolism in the liver and its role in two lysosomal lipidoses - drug-induced phospholipidosis (DIPL) and Sandhoff disease (SD). Emmanuelle Lecommandeur (University of Cambridge, UK)

10:45-11:00 2A-M2: In Search of Metabolic Somnogens: A Unique Signature of Sleep Restriction from Blood in Rats. Arjun Sengupta (University of Pennsylvania, USA)

11:00-11:15 2A-M3: Activation of Fatigue Metabolic Pathway Induces Hepatic Inflammation in a Rat Model of Fatigue. Satoshi Kume (RIKEN Center for Life Science Technologies, Japan)

11:15-11:30 2A-M4: Metabolomics biomarkers of doxorubicin-induced cardiac injury in B6C3F1 mice. Laura K. Schnackenberg (NCTR, US FDA)

11:30-11:45 2A-M5: Metabolomics used as a tool to investigate the signature of etanercept treatment response in a psoriasis patient cohort. Nicholas Rattray (The University of Manchester, UK)

11:45-12:00 2A-M6: Using metabolomics to determine the modes of action of new antibiotics. Isabel Vincent (Glasgow University, UK)

Luncheons

12:30-13:20 Dai-ichi Tsuru Agilent

12:30-13:20 Marica Hall Shimadzu

Session 2P-D: Cancer

Dai-ichi Tsuru

Tomoyoshi Soga & Marta Cascante

13:40-14:00 2P-D1: Oncometabolites: Linking Altered Metabolism With Cancer? Patrick Pollard (University of Edinburgh, UK)

14:00-14:20 2P-D2: Finding the right path: Constructing a temporal network of RAS activity in cancer. Emily Armitage (Universidad San Pablo CEU, Spain)

14:20-14:40 2P-D3: Lipidomic profiling reveals a reconfiguration of sphingolipid metabolism that drives glioma angiogenesis and malignancy. Anthony Don (University of New South Wales, Australia)

14:40-15:00 2P-D4: Enhanced pyruvate carboxylation is crucial to non-small cell lung cancer proliferation and anabolism. Teresa Fan (University of Kentucky, USA)

Session 2P-M: CVD, Diabetes & Neuroscience

Marica Hall

Matej Oresic & Jules Griffin

13:40-13:55 2P-M1: Longitudinal metabolome en route to type 1 diabetes: potential role of gut microbiota and metabolic vulnerability in the early disease pathogenesis. Matej Oresic (Steno Diabetes Center, Finland)

13:55-14:10 2P-M2: Large scale metabolomics in clinical epidemiology. Oliver Fiehn (UC Davis, USA)

14:10-14:25 2P-M3: Examining the effects of metformin in a large clinical cohort and HepG2 and 3T3-L1 treated cells using untargeted LC-MS metabolomics. Emma Boulton (University of Glasgow, UK)

14:25-14:40 2P-M4: Metabolome and lipidome features of human brain development. Kasia Bozek (CAS-MPG Partner Institute for Computational Biology, China)

14:40-14:55 2P-M6: Accumulation of metabolic syndrome risk factors and plasma amino acids and their related metabolites: Tsuruoka Metabolomic Cohort Study. Toru Takebayashi (Keio University School of Medicine)

Poster Session I

15:00-17:00 Marica East For details see the poster page.

15:00-17:00 Dai-ichi Ho-oh For details see the poster page.

Evening Session

17:00-18:20 Dai-ichi Tsuru Thermo Scientific (No registration required)



  • AB SCIEX
  • Agilent Technologies
  • Bruker Corporation
  • Human Metabolome Technologies
  • LECO Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation